SEARCH RESULTS FOR: "Tag: FLXN"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(1)
2017(3)
2016(1)
2015(1)
CATEGORIES
Analyst Downgrades(1)
Buzz Stocks(2)
Investor Sentiment(1)
Stocks On the Move(1)
Technical Analysis(1)

1/4/2019 10:01 AM
Flexion Therapeutics Inc (NASDAQ:FLXN) stock is down 3.2% at $11.94 in early trading, and touched a two-year low of $10.98 out of the gate, after the company announced sub-par full-year revenue guidan...
10/19/2017 12:56 PM
While the broader stock market takes a breather today, we're searching for names bullish options traders may want to target. Based on data provided by Schaeffer's Senior Quantitative Analyst Rocky Wh...
10/9/2017 9:54 AM
U.S. stocks are trading mixed this morning, with the Dow wavering in its early attempts to bounce back from Friday's loss. Among the stocks making moves this morning are pharmaceutical concern Flexi...
3/23/2017 2:34 PM
Financial stocks are leading the Dow higher while a key House vote on healthcare takes center stage. Among specific equities in focus are drug stock Flexion Therapeutics Inc (NASDAQ:FLXN), diagnostic...
2/17/2016 4:51 PM
Biotech stocks haven't been left out of Wall Street's recent success. In fact, the Nasdaq Biotechnology Index (NBI), an exchange-traded fund (ETF) that tracks biotechs' performance on the Nasdaq Com...
PEOPLE ALSO SEARCH FOR

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center